Financial outsourcing provides bedrock for future expansion of growing biopharma

Sampled—a biopharmaceutical leader in biobanking, bioprocessing and analytics—made a strategic decision to carve out from their academic beginnings and form a commercial biorepository. To be operational on Day One and meet its aggressive future growth plans, the company required an experienced provider to address their finance and accounting needs. Sampled engaged RSM US LLP to provide the much-needed financial outsourcing which allowed the company to focus on their core science competencies and growth plans.

And the relationship continues. According to the company’s CEO, Robin Grimwood, “Sampled will continue to grow. We have very aggressive growth expectations, both organically and through M&A. And we see RSM providing a key supporting role for that, allowing us to bring in expertise in different areas at the required time … making sure we have that financial rigor in place to be that bedrock for our future expansion.”

Learn how this outsourcing journey unfolded between client and RSM, and what’s next.

Life sciences companies are challenged with meeting continuous business objectives and needs, while also being mindful of profitability and growth. RSM’s life sciences practice understands this dilemma. From pre-clinical to commercialization, we work with clients through their entire business growth journey to help companies stay focused on their scientific innovations and clinical research while also working toward meaningful business growth.